Aller au contenu principal
Profil bibliographique

Maija Mäki

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

80Publications signalées
3691Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cardiac Imaging and DiagnosticsCardiovascular Function and Risk FactorsMedical Imaging Techniques and ApplicationsAdvanced MRI Techniques and ApplicationsCardiovascular Disease and Adiposity

Les publications récentes

Accès ouvert 2025 article OpenAlex

Lymfactin® gene therapy with vascularized lymph node transfer reduces compression-free swelling and enhances quality of life in breast cancer-related lymphedema: Final Phase I trial results

Susanna Pajula, Anne Saarikko, Sinikka Suominen, Ilkka Kaartinen et autres

BACKGROUND: Lymfactin® is a gene-therapy vector encoding vascular endothelial growth factor C designed to promote lymphatic vessel growth. It is administered during vascularized lymph node transfer (VLNT) to treat breast cancer-related lymphedema. This study presents the final efficacy and long-term safety results …

fi (code pays fourni par la source)

8 citations Journal of Plastic Reconstructive & Aesthetic Surgery
Accès ouvert 2024 article OpenAlex

Phase II Study Shows the Effect of Adenoviral Vascular Endothelial Growth Factor C and Lymph Node Transfer in Lymphedema

Eeva H. Rannikko, Susanna Pajula, Sinikka Suominen, Juha Kiiski et autres

BACKGROUND: Breast cancer-related lymphedema is a common complication lacking medical treatment. Lymfactin is an adenovirus type 5-based gene therapy and prolymphangiogenic growth factor vector that induces vascular endothelial growth factor C expression. The authors' aim was to evaluate the therapeutic effect of …

fi, us, se (code pays fourni par la source)

19 citations Plastic & Reconstructive Surgery
Accès ouvert 2022 article OpenAlex

Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity Lymphedema

Ida-Maria Leppäpuska, Pauliina Hartiala, Sinikka Suominen, Erkki Suominen et autres

BACKGROUND: Lymphedema is a common problem after breast cancer treatment. Lymfactin® is a prolymphangiogenic growth factor vector inducing the expression of human vascular endothelial growth factor C (VEGF-C). It promotes growth and repair of lymphatic vessels. METHODS: Lymfactin® was combined with microvascular …

fi (code pays fourni par la source)

39 citations Journal of Plastic Reconstructive & Aesthetic Surgery
Accès ouvert 2022 article OpenAlex

“Tarkoittaako kehittäminen aina seinien rakentamista?”

Aura Kivilaakso, Maija Mäki

Tässä artikkelissa tarkastellaan Turun historialliseen keskustan ja yliopistojen alueen kehittämissuunnitelmaa suhteessa kaupunkilaisten kokemuksiin ja näkemyksiin kaupunkikeskustasta.Artikkelissa Turun historiallisen keskustan kehittämistä lähestytään kaupunkilaisten osallisuuden ja vaikutusmahdollisuuksien näkökulmasta.Osallisuus nähdään artikkelissa nykykaupunkisuunnittelua ohjaavana narratiivina.Aineistona tutkimuksessa on kehittämissuunnitelman lisäksi hyödynnetty kävelyhaastattelu-ja havainnointiaineistoa.Tulokset kiinnittyvät kaupungissa liikkumiseen, kulkureitteihin …

se, us, bo (code pays fourni par la source)

1 citation Yhdyskuntasuunnittelu
Accès ouvert 2021 article OpenAlex

Long-term Results of Microvascular Lymph Node Transfer: Correlation of Preoperative Factors and Operation Outcome

Eeva H. Rannikko, Sinikka Suominen, Anne Saarikko, Tiina Viitanen et autres

Our objective was to analyze whether a correlation could be observed between preoperative factors and microvascular lymph node transfer outcome after long-term follow-up. METHODS: We included 67 patients in this retrospective case series. The incidence of cellulitis, the difference of arm circumference, …

fi, us (code pays fourni par la source)

16 citations Plastic & Reconstructive Surgery Global Open
Accès ouvert 2019 article OpenAlex

361Association of quantitative myocardial perfusion characteristics and coronary atherosclerosis in patients with normal myocardial blood flow

Teemu Maaniitty, Iida Stenström, E Harjulahti, Maija Mäki et autres

Background: Normal hyperemic myocardial blood flow (MBF) accurately excludes hemodynamically significant coronary artery disease (CAD). However, patients with normal absolute MBF may show relative regional differences in perfusion. We hypothesized that subtle alterations in myocardial perfusion, although within "normal range" in absolute …

fi (code pays fourni par la source)

0 citations European Heart Journal - Cardiovascular Imaging
Accès ouvert 2019 article OpenAlex

P309Prognostic value of global stress myocardial blood flow in patients with suspected obstructive coronary artery disease

E Harjulahti, Iida Stenström, Teemu Maaniitty, Wail Nammas et autres

Funding Acknowledgements: None Background: We have previously demonstrated that reduced regional stress myocardial blood flow (MBF, < 2.3 ml/g/min) by 15O-water positron emission tomography (PET) perfusion imaging accurately detects obstructive coronary artery disease (CAD) and provides prognostic information. It has also been …

fi (code pays fourni par la source)

0 citations European Heart Journal - Cardiovascular Imaging
Accès ouvert 2019 article OpenAlex

Combined Surgical Treatment for Chronic Upper Extremity Lymphedema Patients

Ida-Maria Leppäpuska, Erkki Suominen, Tiina Viitanen, Eeva H. Rannikko et autres

BACKGROUND: Upper limb lymphedema is a common problem after axillary lymph node dissection. Lymphatic drainage can be improved by microvascular lymph node transfer, whereas liposuction can be used to reduce arm volume and excess of adipose tissue. We present the results of …

fi, at (code pays fourni par la source)

43 citations Annals of Plastic Surgery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.